Cancer drug Tagrisso slashes death rate among lung cancer patients, study finds
Tuesday, June 6, 2023 - 12:53
in Health & Medicine
Once-a-day use of the targeted cancer pill Tagrisso (osimertinib) cut the five-year death rate in half for a subset of patients with early-stage lung cancer, a new clinical trial shows.